Home › Funds › GLOBEFLEX CAPITAL L P › RIGL
GLOBEFLEX CAPITAL L P position in RIGL
RIGEL PHARMACEUTICALS INC · Health Care
GLOBEFLEX CAPITAL L P reported holding 112,672 shares of RIGL (RIGEL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$5.4M, representing 0.70% of its reported portfolio and ranking #47 among its reported holdings. GLOBEFLEX CAPITAL L P has disclosed RIGL holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How GLOBEFLEX CAPITAL L P's RIGL position evolved
GLOBEFLEX CAPITAL L P first disclosed a stake in RIGL in Q3 2024 at 9,200 shares (US$149K). The position peaked in Q4 2025 at 217,839 shares, worth US$9.3M. Across 9 filings, GLOBEFLEX CAPITAL L P increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 112,672 shares valued at US$5.4M. Notable position changes include a 468% increase in Q4 2024 (shares rose 7% over the following quarter), a 220% increase in Q2 2025 (shares rose 51% over the following quarter), a 48% trim in Q2 2026 (shares rose 23% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 9.20K | $148.86K | New |
| Q4 2024 | 52.30K | $879.60K | Add |
| Q1 2025 | 52.30K | $940.79K | Hold |
| Q2 2025 | 167.51K | $3.14M | Add |
| Q3 2025 | 217.63K | $6.17M | Add |
| Q4 2025 | 217.84K | $9.33M | Hold |
| Q1 2026 | 217.84K | $5.89M | Hold |
| Q2 2026 | 112.67K | $4.41M | Reduce |
| Q3 2026 | 112.67K | $5.43M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RIGL and 13F data
RIGL (RIGEL PHARMACEUTICALS INC) is a Health Care company. 43 other funds we track also report a position in RIGL — the largest reported positions include Soleus Capital Management, L.P. (US$88.8M), ARMISTICE CAPITAL, LLC (US$74.0M), CM Management, LLC (US$12.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RIGL
- Soleus Capital Management, L.P. 1.84M sh · $88.76M · Q3 2026
- ARMISTICE CAPITAL, LLC 1.54M sh · $73.96M · Q3 2026
- CM Management, LLC 250.00K sh · $12.04M · Q3 2026
- Lionhunter Capital Management, LLC 70.05K sh · $3.37M · Q3 2026
More on GLOBEFLEX CAPITAL L P
FAQ
How long has GLOBEFLEX CAPITAL L P held RIGL?
GLOBEFLEX CAPITAL L P has disclosed RIGL holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is GLOBEFLEX CAPITAL L P's current position in RIGL?
As of Q3 2026, GLOBEFLEX CAPITAL L P holds 112.67K shares of RIGL (RIGEL PHARMACEUTICALS INC), valued at $5.43M, representing 0.70% of its reported portfolio and ranking #47.
Has GLOBEFLEX CAPITAL L P been buying or selling RIGL?
In the latest 13F filing (Q3 2026), GLOBEFLEX CAPITAL L P held unchanged its position in RIGL. The position peaked in Q4 2025 at 217.84K shares.
Which other funds hold RIGL?
Other major institutional holders of RIGL include Soleus Capital Management, L.P., ARMISTICE CAPITAL, LLC, CM Management, LLC, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.